ENHANCED DIAGNOSIS OF ACANTHAMOEBA KERATITIS
棘阿米巴角膜炎的增强诊断
基本信息
- 批准号:2020181
- 负责人:
- 金额:$ 9.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-07-01 至 1999-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: Acanthamoeba keratitis has been considered a relatively rare
and severe form of corneal infection which causes debilitating visual loss.
It has most frequently been associated with the use of contact lenses. The
diagnosis is confirmed with a simple epithelial biopsy and histologic
examination by an ophthalmic pathologist. In the last three years, we have
examined 400 patients with keratitis and have identified 106 patients with
presumed Acanthamoeba in the cornea, each subsequently confirmed with an
epithelial biopsy. In only one case have we been successful in culturing
the organism. It is the PI general hypothesis that Acanthamoeba keratitis
represents an underdiagnosed opportunistic infection of the human cornea
which can present a significant health hazard. It is much more common than
previously thought. The diagnosis and management of this disease will be
greatly improved with more precise and rapid diagnostic tools including
confocal microscopy and polymerase chain reaction (PCR). We propose in this
research to: 1) Determine the prevalence of subclinical or asymptomatic
Acanthamoeba infection in the normal population by examining, with confocal
microscopy, a series of normal patients and patients undergoing epithelial
removal prior to PRK for myopia. Examine Eye Bank eyes with confocal
microscopy, histology, and PCR for the presence of amoeba. 2) Determine the
prevalence of clinical, subclinical, or asymptomatic corneal acanthamoeba
infections in patients with various forms of keratopathy including presumed
bacterial keratitis, diabetic epitheliopathy, basement membrane dystrophy,
herpes simplex keratitis and herpes zoster keratitis and confirm the
diagnosis with histology, culture and PCR. 3) Determine the prevalence of
clinical or subclinical acanthamoeba infection in patients particularly
prone to acute infection including patients wearing contact lenses who have
normal epithelium or evidence of epithelial disease such as punctate
keratitis or microcysts. Patients with clinical and confocal evidence of
disease will have an epithelial biopsy for further diagnosis. 4)
Characterize the organisms we have identified by developing a polymerase
chain reaction (PCR) assay, enhance our culture techniques, and thereby
characterize more precisely these organisms.
描述:阿米巴角膜炎被认为是一种相对罕见的
严重的角膜感染会导致视力下降。
它最常与使用隐形眼镜有关。 的
通过简单的上皮活检和组织学检查确诊
由眼科病理学家进行检查。 在过去的三年里,
检查了400例角膜炎患者,并确定了106例
角膜中的假定阿米巴,随后用
上皮活检 只有一个案例我们成功地培养了
有机体 PI的一般假设是阿米巴角膜炎
代表了一种未被诊断的人类角膜机会性感染
这会对健康造成严重危害。 它比普通的
以前认为。 这种疾病的诊断和管理将是
通过更精确、更快速的诊断工具,
共聚焦显微镜和聚合酶链反应(PCR)。 我们在此建议
研究目的:1)确定亚临床或无症状的患病率
共聚焦显微镜检查正常人群阿米巴感染
显微镜下,一系列正常患者和接受上皮细胞移植的患者
在近视矫正前摘除。 检查眼库眼睛与共聚焦
显微镜检查、组织学检查和PCR检查是否存在阿米巴。 2)确定
临床、亚临床或无症状角膜棘阿米巴的患病率
各种形式的角膜病患者的感染,包括假定的
细菌性角膜炎、糖尿病性上皮病、基底膜营养不良,
单纯疱疹性角膜炎和带状疱疹性角膜炎,并确认
组织学、培养和PCR诊断。 3)确定以下疾病的患病率
临床或亚临床棘阿米巴感染的患者,
易受急性感染,包括戴隐形眼镜的病人,
正常上皮或上皮疾病的证据,如点状
角膜炎或微囊肿。 有临床和共聚焦证据的患者
疾病将有一个上皮活检进一步诊断。 四、
通过开发聚合酶来表征我们已经鉴定的生物体
链反应(PCR)检测,提高我们的培养技术,从而
更准确地描述这些生物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM D MATHERS其他文献
WILLIAM D MATHERS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM D MATHERS', 18)}}的其他基金
In Vivo Imaging of Leukocyte-Endothelial Dynamics
白细胞内皮动力学的体内成像
- 批准号:
6614375 - 财政年份:2003
- 资助金额:
$ 9.48万 - 项目类别:
In Vivo Imaging of Leukocyte-Endothelial Dynamics
白细胞内皮动力学的体内成像
- 批准号:
6732733 - 财政年份:2003
- 资助金额:
$ 9.48万 - 项目类别:
In Vivo Imaging of Leukocyte-Endothelial Dynamics
白细胞内皮动力学的体内成像
- 批准号:
6874846 - 财政年份:2003
- 资助金额:
$ 9.48万 - 项目类别:
MEIBOMIAN GLAND DYSFUNCTION IN CHRONIC BLEPHARITIS
慢性睑缘炎的睑板腺功能障碍
- 批准号:
2163864 - 财政年份:1992
- 资助金额:
$ 9.48万 - 项目类别:
MEIBOMIAN GLAND DYSFUNCTION IN CHRONIC BLEPHARITIS
慢性睑缘炎的睑板腺功能障碍
- 批准号:
3267372 - 财政年份:1992
- 资助金额:
$ 9.48万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 9.48万 - 项目类别:
Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 9.48万 - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 9.48万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 9.48万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 9.48万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 9.48万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 9.48万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 9.48万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 9.48万 - 项目类别:
Mentoring Scientists for Careers in HIV Translational Clinical Research
指导科学家从事艾滋病毒转化临床研究
- 批准号:
10762827 - 财政年份:2023
- 资助金额:
$ 9.48万 - 项目类别: